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Abstract
Background: Familial spastic paraplegia (FSP) is a heterogeneous group of dis-
orders characterized primarily by progressive lower limb spasticity and weakness.
More than 50 disease loci have been described with different modes of inheri-
tance. Recently, we described a novel missense mutation (c.803G>A, p.R268Q)
in the plasma membrane calcium ATPase (PMCA4, or ATP2B4) gene in a Chi-
nese family with autosomal dominant FSP. Further to this finding, here we
describe the functional effect of this mutation. Methods: As PMCA4 removes
cytosolic calcium, we measured transient changes and the time-dependent decay
of cytosolic calcium level as visualized by using fura-2 fluorescent dye with con-
focal microscopy in human SH-SY5Y neuroblastoma cells overexpressing either
wild-type or R268Q mutant PMCA4. Results: Overexpressing both wild-type
and R268Q PMCA4 significantly reduced maximum calcium surge after KCl-
induced depolarization as compared with vector control cells. However, cells
overexpressing mutant PMCA4 protein demonstrated significantly higher level of
calcium surge when compared with wild-type. Furthermore, the steady-state
cytosolic calcium concentration in these mutant cells remained markedly higher
than the wild-type after SERCA inhibition by thapsigargin. Conclusion: Our
result showed that p.R268Q mutation in PMCA4 resulted in functional changes
in calcium homeostasis in human neuronal cells. This suggests that calcium
dysregulation may be associated with the pathogenesis of FSP.
Introduction
Familial spastic paraplegia (FSP) is a clinically and geneti-
cally heterogeneous group of diseases characterized by
progressive lower limb spasticity and weakness, and is
classified according to phenotype, mode of inheritance,
and the mutated gene (Blackstone 2012). Pure FSP is
characterized by progressive lower limb weakness and
spasticity and may be associated with urinary urgency,
mild impairment of vibration sense, and proprioception.
The upper limbs are spared and there is no bulbar dys-
function. Complex FSP is characterized by additional
manifestations such as cognitive impairment, epilepsy,
cerebellar ataxia, extrapyramidal disturbances, optic atro-
phy, and peripheral neuropathy. Neuroimaging may show
white matter lesions, thin corpus callosum, and spinal
cord atrophy. FSP can be inherited in an autosomal dom-
inant, autosomal recessive, or X-linked fashion (Finsterer
et al. 2012). Different mutations in the same gene can
cause either pure or complex FSP, and intrafamilial phe-
notypic variability is high, greatly complicating the
genetic diagnosis of FSP. Seventy-one forms of FSP
(SPG1 to SPG48) have been described involving many
gene loci (Novarino et al. 2014), with 20 or more loci
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associated with autosomal dominant FSP (Finsterer et al.
2012). The associated genes have been reported to be
involved in organelle and microtubule dynamics, endo-
plasmic reticulum homoeostasis, transport, and signal
transduction.
Recently, we described a novel causative mutation,
c.803G>A, p.R268Q in the PMCA4 gene in a Chinese fam-
ily with autosomal dominant FSP (Li et al. 2014). This
mutation was predicted to be pathogenic based on multiple
deleteriousness prediction algorithms. PMCA4 is known to
have protein–protein interaction and shares similar cellular
pathways with some known causal genes of FSP and spi-
nocerebellar ataxias. Computational modeling of the
mutant PMCA4 protein showed that the mutation, which
is located in a protein aggregation-prone segment, may
result in a higher folding free energy. In this study, we
aimed to further study the functional impact of this muta-
tion on calcium transient using human neuroblastoma
cells. We demonstrated that the R268Q mutation signifi-
cantly decreased the efficiency of suppressing depolariza-
tion-induced calcium overload in these cells when
compared with cells overexpressing wild-type PMCA4.
Materials and Methods
Cloning of human PMCA4 transcript
Full-length human PMCA4 isoform b (Protein ID:
ENSP00000350310) cDNA was amplified from total RNA
extracted from HEK-293 cells. The gene-specific primers
used were as followed: PMCA4b-forward, 50-ATCGGA
TCCATGACGAACCCATCAGACC, and PMCA4b-reverse,
50-ATCGCGGCCGCTCAAACTGATGTCTCTAGGCTCT.
A mutated mega-primer, prepared using PMCA4b-forward
and PMCA4b-M-reverse, 50-CATCTGGCCAGAACCTT,
along with PMCA4b-reverse was used to amplify the
mutant form of PMCA4b (PMCA4b-mut, 803G>A) using
full-length wild-type PMCA4b amplicon as template. The
PCR products were then subcloned into mammalian
expression vector, pcDNA3.1(+), and transformed into
E. coli (DH5a). Positive clones containing either PMCA4b
or mut-PMCA4b were confirmed with sequencing.
Cell culture
Human neuroblastoma SH-SY5Y cells (CRL-2266; ATCC)
were cultured in DMEM-F12 supplemented with 10%
FBS, 2 mmol/L glutamine and 100 lg/mL penicillin-
streptomycin (Invitrogen, Hong Kong) at 37°C in humid-
ified 5% CO2 atmosphere. Expression plasmids containing
transcript of either wild-type or mutant PMCA4 were
transfected into SH-SY5Y cells using Lipofectamine2000
(Invitrogen). Twenty-four hours after transfection, cells
were selected using geneticin (G-418) at 250 lg/mL until
resistant clones were obtained.
Real-time PCR
Total ATP2B4 mRNA expression was determined by quan-
titative RT-PCR. Total RNA was isolated and digested with
DNase I as previously described (Ho et al. 2010). The
OD260/280 ratio of extracted RNA was kept above 1.95 to
ensure purity and integrity. Reverse transcription was per-
formed using total RNA by AccuScript High Fidelity 1st
Strand cDNA synthesis kit (Agilent Technology, Santa
Clara, CA). Amplification reactions were performed using
Power SYBR Green PCR Master Mix (Applied Biosystems)
according to manufacturer’s protocol. The primers for
real-time PCR: PMCA4b-forward: GCAATACCTACCCG-
ATCCCTG; PMCA4b-reverse: ACCGCATTGTTGTTTGT-
ATTGG. GAPDH expression was used to normalize for
mRNA loading. Each RNA sample was run in triplicate and
repeated in at least three independent treatments.
Western blot
Overexpression of PMCA4 was confirmed using SDS-
PAGE western blotting. Equal amount of total cell lysates
extracted in standard RIPA were subjected to polyacryl-
amide gel electrophoresis, followed by standard western
blotting procedures. Antibodies against total PMCA4
(Pierce, MA1-914) and b-actin (Santa Cruz, sc-1615)
were used to detect the proteins, respectively. Relative
expression level of target proteins was determined by the
band intensity as measured using densitometry.
Intracellular calcium level [Ca2+]i
measurement
Human SH-SY5Y cells (2 9 105 cells/well) were plated in
24-well plates coated with 100 or 10 lg/ml poly-L-lysine
(Sigma, St. Louis, MO) with DMEM/F12 at 37°C over-
night for adherence. To determine the effects of PMCA4
mutation on the intracellular calcium transient, cells stably
overexpressing either wild-type or mutant PMCA4 were
labeled with 5 lmol/L fura2-AM fluorescent dye (Invitro-
gen) in serum-free DMEM for 20 min in darkness at room
temperature. After subsequent washes with Gey’s balanced
salt solution (GBSS), cells were incubated in GBSS for a
further 10 min at 37°C to allow de-etherification of AM
esters. Labeled cells were put on the stage of an Olympus
inverted epifluorescence microscope (Olympus, Tokyo)
and visualized using a 20 9 objective. Images were col-
lected by a CCD camera every 2 sec and analyzed using
Olympus Cell R Imaging System (Olympus, Germany) at
room temperature with excitation of 340 and 380 nm, and
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emission was measured at 510 nm. Ratio (R) of F340/F380
was obtained after subtracting background noises. Cells
were allowed to stabilize for 20 sec and baseline ratios (Ro)
were obtained prior to addition of potassium chloride
(KCl, 100 mmol/L) to induce membrane depolarization,
or incubation with the SERCA inhibitor, thapsigargin (TG,
0.5 lmol/L). The measurement continued for 4 min after
addition of KCl or TG. The relative changes in intracellular
calcium levels [Ca2+]i, indicated as normalized ratio (R/
Ro), were plotted against time. Intracellular concentration
of calcium was calculated using the general formula,
[Ca2+]i = Kd * Q(R-Rmin)/(Rmax-R). (Kd =183 nmol/L).
Kd is the dissociation constant for Ca2+ binding to the
indicator, R is the fluorescence intensity ratio between
emission at 340 and 380 nm with fura-2. Q is the ratio of
minimum (Fmin) to maximum (Fmax) intensity at OD380.
Fmax was determined by exposing cells to 1.5 mmol/L Ca
2+
and 5 lmol/L ionomycin, and Fmin was determined by the
addition of 4 mmol/L EGTA and 5 lmol/L ionomycin
to cells.
Statistical analysis
Statistical analyses were carried out using the Prism
(GraphPad Software Inc., San diego, CA). Data are
expressed as mean  standard error mean (SEM) from at
least three independent experiments. Statistical signifi-
cance among individual groups was calculated by the Stu-
dent’s t-test. The time dependent decay in cytosolic
calcium was assessed by analysis of extra sum-of-squares
F test after fitting of one phase decay (t1/2). Differences
were considered significant at a level of P < 0.05.
Results
R268Q mutant PMCA4 delayed calcium
extrusion after induced calcium transient
To assess the cellular functional impact of the p.R268Q
mutation on PMCA4, we overexpressed either wild-type or
mutant PMCA4 protein in human SH-SY5Y cells and
assessed changes in intracellular calcium transient. Overex-
pression of either wild-type or mutant PMCA4 was con-
firmed by western blotting using antibodies against PMCA4
and b-actin (Fig. 1A), and real-time RT-PCR (Fig. 1B). To
assess the efficiency of intracellular calcium extrusion, addi-
tion of KCl was used to induce membrane depolarization
and calcium transient. KCl treatment caused immediate
increase in [Ca2+]i in all test groups, as indicated by a rapid
increase in OD340/380 ratio under confocal microscopy
(Fig. 2A). Cells overexpressing either wild-type or mutant
PMCA4 had lower maximum [Ca2+]i than empty-vector
control (P < 0.01) (Vector controls: 1051.87  54.9 lmol/
L; PMCA4(WT): 769.0  16.1 lmol/L; PMCA4(R268Q):
843.9  20.6 lmol/L) (Fig. 2B), suggesting that overexpres-
sion of either wild-type or mutant PMCA4 both increased
calcium extrusion activity. However, R268Q mutant cells
demonstrated significantly higher maximum calcium surge
compared to wild-type (all P < 0.0001) (Fig. 2A). After the
initial influx, OD340/380 ratio was gradually restored back
towards basal level by plasma membrane calcium transport-
ers. There was no statistical difference in time-dependent
decay (t1/2) of calcium surge between cells overexpressing
WT (t1/2 = 23.06) and mutant PMCA4 (t1/2 = 22.26), (95%
confidence intervals: WT = 22.36–23.80; R268Q
mutant = 21.51–23.07; P = 0.1502) based on extra sum-of-
squares F test in one phase decay analysis. To further eluci-
date the contribution of PMCA4 to the calcium transient,
we performed additional experiments to measure the steady
state [Ca2+]i after incubation with SERCA inhibitor, thapsi-
gargin (TG; 500 nmol/L) (Fig. 3A). The steady-state [Ca2+]i
in cells overexpressing mutant PMCA4 after exposure to TG
was significantly higher than cells overexpressing WT
PMCA4 (WT: 732.3  13.0 lmol/L vs. R268Q:
785.4  16.1 lmol/L; P < 0.05; n > 92) (Fig. 3B).
Discussion
Calcium is important in controlling vital processes in
cells, and its movement and concentration must be tightly
(A) (B)
Figure 1. (A) Western blot showing stable
overexpression of either wild-type (WT) or
R268Q mutant ATP2B4 protein at similar
level in SH-SY5Y cells. (B) ATP2B4 mRNA
levels in WT and mutant stably
overexpressing cells were similar as shown
by quantitative real-time PCR. ** represents
statistical significance at p<0.01 as
compared to vector. ns: Not statistically
significant.
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regulated. Dysregulation of calcium homeostasis has been
shown to be involved in neurodegenerative conditions
such as Alzheimer’s disease and Parkinson’s disease
(reviewed in Zundorf and Reiser 2011). In the plasma
membrane, there are two calcium exporting systems: the
Na+/Ca2+ exchanger which functions as a large capacity,
poor Ca2+ affinity system to dispose of periodic arrival of
large Ca2+ loads, and the PMCAs, which are only present
in small amounts, have high Ca2+ affinity, and are
thought to be important in the fine-tuning of Ca2+ signals
(Giarcomello et al. 2013).
PMCA4 belongs to the family of plasma membrane
Ca2+-ATPases consisting of four isoforms with dozens of
variants generated by alternative RNA splicing (Strehler
and Zacharias 2001). Once thought to have general
house-keeping functions in extruding calcium from cells,
the PMCAs are now thought to have more specialized
roles in the regulation of the extent, localization, and
magnitude of calcium movement across the plasma mem-
brane, as accumulating evidence has shown that the
expression and localization of different isoforms and
splice variants of PMCAs are tightly regulated (Giarcom-
ello et al. 2013). PMCAs have been reported to be associ-
ated with the pathogenesis of various human disorders.
Pump dysregulation of nongenetic origin has been associ-
ated with cancer, and potential therapeutic opportunities
by developing agents that modulate PMCA activity are
being explored (Brini et al. 2013). Pump defects of
genetic origin have also been described in PMCA2 and
PMCA3, mutations of which cause hereditary deafness
(A) (B)
Figure 2. (A) Real-time plot of changes in cytosolic calcium level in SH-SY5Y cells overexpressing either WT or R268Q mutant ATP2B4 by KCl-
induced depolarization. Cells were labeled with 5 lmol/L fura2-AM fluorescent dye in serum-free DMEM for 20 min at room temperature.
Relative changes in intracellular calcium levels [Ca2+]i, indicated as normalized OD340/380 ratio were plotted against time. Dotted lines represent
95% confident intervals (CI) of the corresponding curves. (B) Maximum cytosolic calcium surge indicated as KCl-induced peak [Ca2+]i of individual
cells within the monitored period are shown in bar chart. N = Number of individual cells measured in each group. Data represent mean  SD.
Comparison between groups was performed using unpaired t-test. R268Q mutant ATP2B4 significantly delayed attenuation of KCl-induced
calcium surge compared to wild-type. **represents statistical significance as compared with vector controls at P < 0.01; ##represents P < 0.01
between the two designated groups.
(A) (B)
Figure 3. (A) Real-time plot of changes in cytosolic calcium level in SH-SY5Y cells overexpressing either WT or R268Q mutant ATP2B4 by SERCA
inhibition using thapsigargin. Cells were labeled with 5 lmo/L fura2-AM fluorescent dye in serum-free DMEM for 20 min at room temperature.
Relative changes in intracellular calcium levels [Ca2+]i, indicated as normalized OD340/380 ratio were plotted against time. (B) The mean of
maximum steady level of cytosolic calcium of individual cells within the monitored period are shown in bar chart. N = Number of individual cells
measured in each group. Data represent mean  SD. Comparison between groups was performed using unpaired t-test. Cells overexpressing
R268Q mutant protein demonstrated significantly higher cytosolic calcium concentration compared to wild-type. *represents statistical significance
as compared with WT at P < 0.05.
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and X-linked cerebellar ataxia in humans, respectively
(Strehler 2013). Our previous finding of a PMCA4 muta-
tion causing FSP expanded the spectrum of phenotypes
associated with PMCA mutations in humans.
The expression of PMCA4 is highly regulated tempo-
rally and spatially. During development, mRNA of
PMCA4 is expressed at low levels except in the liver. At
later developmental states, its expression in the liver
decreases while it increases in the nervous system and a
few other tissues. In adult rats, PMCA4 is expressed ubiq-
uitously, most notably in the brain, the heart, and the
spermatozoa (Giarcomello et al. 2013). Even within the
adult brain, expression of different splice variants of
PMCA4 is highly regulated: the full length variant b is
present in various regions including the cerebellum,
whereas the C-terminally truncated variant a is most
abundant in the frontal cortex (Filoteo et al. 1997). This
specialization in the expression of different PMCA4 vari-
ants suggests that they likely serve specific functions in
different regions of the brain.
Of the 4 PMCA isoforms, PMCA4 is the only one
which is localized in lipid rafts in pig cerebellum (Sep-
ulveda et al. 2006). Lipid rafts are specialized lipid
domains containing sphingolipids and cholesterol which
provide a platform for the assembly of protein com-
plexes involved in signal transduction. They are found in
neuronal dendrites where postsynaptic protein complexes
are localized. Thus, localization of PMCA4 in lipid rafts
suggests that it may play a role in signaling pathways at
synaptic nerve terminals, where the synaptic activity is
highly dependent on calcium signaling (Simons and Too-
mre 2000). Lipid rafts are also involved in conforma-
tional changes in proteins underlying the formation of
amyloid plaques in Alzheimer’s disease and prion dis-
eases (Fantini et al. 2002). Mutations in PMCA4 may
therefore contribute changes in lipid raft functions lead-
ing to neurodegeneration.
In this study, we showed that the R268Q mutation of
the PMCA4 gene had functional implication and resulted
in increased maximum KCl-induced calcium transient.
Even though the absolute difference of the two peak
ratios between WT and mutant PMCA4 appeared to be
small at 74 lmol/L, the difference was statistically signifi-
cant with measurements from more than 600 individual
cells in three independent cultures. We have also shown
that even after controlling for the contribution of SERCA
in cytosolic calcium concentration, the delay and impair-
ment in calcium extrusion remained significant in cells
overexpressing mutant PMCA4 compared with WT. Con-
sidering that the typical basal [Ca2+]i is maintained at
submicromolar level, this small difference may be suffi-
cient to cause significant differences in the many down-
stream calcium-sensitive intracellular signaling pathways
(Nutt et al. 2002). Moreover, the transient accumulation
of free Ca2+ (calcium overload) between neuronal excita-
tion in cells overexpressing mutant PMCA4 may result in
subsequent activation of various cell death pathways, for
example, Ca2+-dependent synthases and proteases to dam-
age cytoskeleton, membrane, and DNA leading to excito-
toxicity and neuronal death (Gleichmann and Mattson
2011). Indeed, previous work with mutant PMCA2 asso-
ciated with hereditary deafness in humans has shown that
the mutant pumps were defective in the removal of cal-
cium from the cytosol (Giacomello et al. 2011). Mutation
in PMCA3, which was found in a family with congenital
X-linked cerebellar ataxia, was also found to reduce the
ability of the PMCA3 pump to return calcium level to
baseline after stimulation of calcium influx (Zanni et al.
2012). Thus, it is likely that the R268Q mutation in
PMCA4, which causes functional impairment in calcium
extrusion similar to mutated PMCA2 and PMCA3, plays
a role in the pathogenesis of the clinical phenotype of
FSP.
Taken together, we believe that the R268Q mutation in
PMCA4 caused neuronal deficits associated with FSP.
This is the first report to demonstrate a PMCA4 mutation
which caused functional changes in calcium extrusion to
be associated with autosomal dominant FSP, indicating
that calcium dysregulation may be involved in the patho-
genesis of spastic paraplegia. The detailed pathogenic
mechanisms of how impairment in neuronal calcium flux
can directly cause the disease phenotype in FSP require
further studies.
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